|
|
||||||||
,1
* Department of Large Animal Clinical Science, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan 069-8501
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706
1 Corresponding author: groetzel{at}wisc.edu
| ABSTRACT |
|---|
|
|
|---|
Key Words: dairy cow fasting model hepatic lipidosis insulin response
| INTRODUCTION |
|---|
|
|
|---|
Insulin resistance is defined as a state in which normal concentrations of insulin produce a less than normal biological response (Kahn, 1978). States of insulin resistance may consist of decreased insulin sensitivity (i.e., a high insulin dose required to produce a half-maximal response in blood glucose concentration), decreased insulin responsiveness (i.e., a low maximal blood glucose response to a high dose of insulin), or a combination of both decreased insulin sensitivity and responsiveness. Different mechanisms may lead to decreased insulin sensitivity or decreased insulin responsiveness (Kahn, 1978).
States of insulin resistance have not been well characterized in dairy cattle. The gold standard test for diagnosing insulin resistance in human medicine is the hyperinsulinemiceuglycemic clamp (Monzillo and Hamdy, 2003). The hyperinsulinemiceuglycemic clamp has been used in small-scale studies to study metabolism in dairy cattle (Holtenius et al., 2000; Mashek et al., 2001). Because of practical limitations, this method has not been used in larger studies, and it has not been used to determine whether spontaneous insulin resistance is present in dairy cattle. Insulin responsiveness may be evaluated by insulin tolerance tests, which are more practical to conduct. Insulin tolerance tests involve intravenously administering a fixed bolus of insulin (about 0.1 U/kg) and then measuring the plasma glucose decrement during a 60-min period (Monzillo and Hamdy, 2003). Ohtsuka et al. (2001) reported decreased insulin response (blood glucose response 30 min after an i.v. bolus of 0.05 U/kg insulin) in dairy cows with spontaneous fatty liver. Many of these cows had severe hepatic lipidosis, and insulin response decreased with increasing severity of hepatic lipidosis (Ohtsuka et al., 2001). Kushibiki et al. (2001) reported decreased insulin response (blood glucose response 0 to 240 min after an i.v. bolus of 0.2 U/kg insulin) in Holstein steers following prolonged treatment with tumor necrosis factor-
. Tumor necrosis factor-
has been associated with hepatic lipidosis. Ohtsuka et al. (2001) reported more than 3-fold greater concentrations of tumor necrosis factor-
in dairy cows with severe hepatic lipidosis than cows with mild fatty liver.
Fasting is an alternative method to induce hepatic lipidosis (Mohamed et al., 2004; Mashek et al., 2005). Fasting causes NEB and accelerated mobilization of NEFA from adipose tissues to the liver. Fat accumulates in the liver when hepatic fatty acid uptake and esterification exceed the capacity of the liver to either oxidize fatty acids or export them as very low density lipoproteins (Gerloff et al., 1986). Fasting increased liver triglycerides (TG) more than 2.5-fold and reduced hepatic extraction of bile acids (Mohamed et al., 2004). Insulin response has not been evaluated in a fasting model.
The purposes of this study were to determine whether insulin response is decreased during a 4-d fasting model, and to evaluate the relationship between insulin response and other metabolic changes that accompany fasting.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cows were maintained in individual tie stalls. Their care adhered to the laboratory animal control guidelines of Rakuno Gakuen University. Before and after fasting, cows were fed a concentrate mix at the rate of 0.5% of BW on a DM basis twice daily (0800 and 1700 h) and a constant amount of grass hay (about 0.5% of BW/d, DM basis). Feed refusals were negligible throughout the trial. A concentrate mix contained approximately 18% CP, 2% crude fat, and 1.69 Mcal of NEL/kg (DM basis). Water and free-choice minerals were available ad libitum for all cows throughout the experimental period. To reduce risk of gastrointestinal dysfunction upon refeeding, the concentrate mix was gradually reintroduced to the fasted cows for the first 2 d after the end of the fasting period.
Experimental Procedure and Blood Sampling
The duration of the experiment was 26 d. The experiment consisted of 3 periods: prefasting, fasting, and postfasting. The beginning of the prefasting period was designated as d 5. The fasting period started on d 0 and ended on d 4. The postfasting period started on d 4 and continued until d 20. The BCS and BW of each cow were determined at approximately 0700 h on d 3, 4, 12, and 20. The BCS was recorded as the average of 2 scores assigned independently by 2 evaluators using a 5-point scale (Edmonson et al., 1989). Evaluators could not be blind to treatment assignments because cows in the fasted group had visually apparent changes in behavior and abdominal fill during the fasting period.
Deep catheters (14 gauge x 30 cm) fitted with extension tubes (Togomedikit, Tokyo, Japan) were placed in both jugular veins of each cow 1 d before the start of the prefasting period. All catheters were flushed twice daily with a 3.8% sodium citrate solution. Catheters that lost patency were replaced; this happened approximately once for each cow during the trial.
Blood was collected for NEFA, BHBA, and glucose determinations on d 5, 3, 1, 0, 1, 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 18, and 20. Blood was collected for insulin determinations on d 3, 1, 4, 10, and 20. Blood samples were collected via jugular catheter into a plastic syringe at about 0730 h. Blood was then transferred into heparinized tubes (for NEFA, BHBA, and insulin analyses) and into tubes containing NaF for blood for glucose analysis. Tubes were placed in ice immediately after collection and centrifugation (2,500 x g for 15 min at 4°C) was started within 10 min of collection. Separated plasma was immediately frozen and stored at 80°C until analysis.
Insulin Tolerance Test
Insulin-stimulated blood glucose response (ISBGR) was determined on d 3, 4, 12, and 20 using a modification of the protocol described by Ohtsuka et al. (2001). Blood samples were collected at 10 and 0 min for baseline blood glucose analyses, and the average value was recorded. Immediately after the 0-min sample was collected, cows were given a bolus i.v. dose of insulin (0.05 U/kg; Novolin R; Novo Nordisk Pharma Ltd., Tokyo, Japan) through the opposite jugular catheter. A blood sample was collected 30 min later. Blood samples for the glucose assays used in the ISBGR determinations were collected and processed as described previously for the blood glucose tests. The ISBGR was calculated by the formula: ISBGR (%) = [(G0 G1)/G0] x 100, where G0 is the baseline glucose concentration and G1 is the glucose concentration 30 min after insulin infusion.
Liver Specimens
Liver biopsies were obtained on d 3, 4, 12, and 20. Biopsy samples were collected at 1100 h (approximately 3 h after the completion of the ISBGR evaluation), which allowed sufficient time for blood glucose to return to normal concentrations. Cows were sedated with i.v. xylazine (0.07 mg/kg of BW) before sampling. The biopsy area was surgically prepared and infiltrated with 10 mL of 2% procaine hydrochloride. Placement of the biopsy needle to collect the liver tissue was guided by ultrasonography. Liver biopsy samples (about 0.4 g per sample) were rinsed in sterile saline solution, frozen in liquid N2, and stored at 80°C.
Blood Analyses
Plasma concentrations of NEFA, BHBA, and glucose were determined using a clinical biochemistry autoanalyzer (BioMajesty JCA-BM 2250; JEOL Ltd., Tokyo, Japan). Plasma NEFA was determined enzymatically using a commercial kit (N-assay NEFA; Nittobo Medical Ltd, Tokyo, Japan) according to the procedure of Okabe and Uji (1999). Plasma BHBA was determined enzymatically using a commercial kit (3-OHBA-TR; Kishimoto Clinical Laboratory, Sapporo, Japan) according to the procedure of Hidaka (1999). Plasma glucose was determined enzymatically using a commercial kit (GLU-TR; Kishimoto Clinical Laboratory) according to the procedure of Ono (1999). Plasma insulin concentration was measured by radioimmunoassay (Itoh et al., 1997). Intra-assay coefficient of variation for the plasma insulin determinations was 4.8%. Liver TG content was determined on a wet basis by colorimetric assay (Snyder and Stephens, 1959).
Statistical Analyses
Effects of fasting on blood constituents were analyzed as repeated measures using the MIXED procedures in SAS (SAS Institute, 1999). Cow was included as a random effect in the model, and effects of treatment (fasted vs. control), day, and treatment x day interactions were evaluated. Covariance was structured as spatial powers; this approach resulted in the lowest Akaike information criterion values (Akaike, 1974) compared with unstructured and compound symmetry approaches. Residual plots were evaluated for heteroscedasticity of the residual plots, and different data transformations were evaluated and applied as needed. A log10 transformation was applied to BW, liver TG, NEFA, insulin, and BHBA data. Other outcomes (BCS, glucose, and ISBGR) did not require transformation. Least squares means and standard errors presented in the results and figures are from untransformed data using the final models. Standard errors of the means were calculated for each treatment and pooled by day. Because the study included many days of comparisons for fasted and control cows, P-values were adjusted according to Bonferronis inequalities (Snedecor and Cochran, 1989).
Correlations between study outcomes were calculated for data collected on d 4 (the last day of the fasting period). Some of the study outcomes on d 4 failed tests for the assumption of normal distribution, so correlation analysis was done with Spearman rank-order correlation coefficients (Snedecor and Cochran, 1989).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Changes in BW, BCS, and NEFA in response to the 4-d fast were similar to those observed in other studies (Mohamed et al., 2004; Mashek et al., 2005). The NRC (2001) estimates that cows lose 6.9% of BW when BCS decreases from 3.5 to 3.0. In this study, BCS decreased from 3.46 to 3.04 and BW decreased 8%. Loss of ingesta caused by fasting could explain why the BW loss was greater in the current study compared with expected BW losses in fed animals reported by NRC.
The BCS was decreased (P <0.05) in fasted cows on d 4 compared with control cows. The BCS was positively correlated (P <0.01) with ISBGR and was negatively correlated with NEFA (P <0.05) and BHBA (P <0.01; Table 1
). Body weight was not correlated with any outcomes. These results indicate that rapid loss in BCS may be a useful monitor of underlying NEB, but that BW is not reliable for this purpose.
An increased liver TG content is expected in fasted cows, and the magnitude of increased liver TG in this study was similar to increases observed after a 6-d fast (Brumby et al., 1975). None of the BHBA concentrations in the current study exceeded the cut-point of >1.40 mM described as the threshold for subclinical ketosis in early-lactation dairy cows (Duffield, 2000). Thresholds for subclinical ketosis for nonlactating cows have not been defined. Blood ketone concentrations in the current study were not as high as those observed in field studies for subclinical ketosis in early-lactation cows (Oetzel, 2004). Several factors may explain this difference. First, nonlactating cows are less susceptible to the developing ketonemia than are cows in early lactation. Second, fasting for only 4 d may not be enough time to induce ketogenesis. Fasting for 6 d (Baird et al., 1979) caused a much larger BHBA response in non-lactating cows, similar to BHBA concentrations observed in spontaneously ketotic cows. Veenhuizen et al. (1991) noted that the first response observed during a ketosis induction protocol in early-lactation cows was increased blood NEFA. The second response was increased liver TG. Increased blood BHBA concentration was the third response, and this began only after blood NEFA and liver TG concentrations had already risen. These findings indicate that a longer fasting period may have increased BHBA concentrations.
The reduction in blood BHBA in cows 2 d after the end of the fast could be explained by increased insulin after refeeding, which would be expected to reduce blood ketones. However, blood insulin was not measured from the end of the fast until 6 d later (d 10) in the current study.
Baseline blood glucose concentrations measured at 10 min and at 0 min before the insulin tolerance testing were virtually identical (data not shown) for each test and for every cow. These data indicate that cows were well acclimated to blood sampling via the jugular catheters and apparently did not experience a stress response (which could increase the blood glucose concentration) when blood samples were collected.
The insulin tolerance test used in this study evaluated the blood glucose concentration at a single time point after insulin administration. Data from previous reports indicate that the average time to nadir for the plasma glucose concentration consistently occurs approximately 30 min after i.v. insulin administration, even when different insulin formulations and doses are administered (Chilliard and Ottou, 1995; Lemosquet et al., 1997; Baumgard et al., 2002). Individual cows may reach blood glucose nadir at different times. Therefore, the current protocol is less accurate than measuring blood glucose every 5 min for 60 min after insulin dosing and then calculating the slope of the linear decline in blood glucose as described by Monzillo and Hamdy (2003). In the current study, the magnitude of the effect of fasting on ISBGR was almost 2-fold and was highly significant (P = 0.003 after adjustment for Bonferronis inequalities).
Blood NEFA was negatively correlated (P <0.05) with ISBGR on d 4, indicating that NEFA may play a role in reducing insulin responsiveness. Other studies have associated increased NEFA with changes in insulin metabolism. Strang et al. (1998) reported that exogenous NEFA reduced insulin clearance in bovine hepatocytes. Elevated NEFA increased the risk for insulin resistance in Zucker diabetic fatty rats (Lee et al., 1994). Increased NEFA has also been reported to cause ß-cell apoptosis in Zucker diabetic fatty rats (Shimabukuro et al., 1998), and prolonged elevation of plasma NEFA can desensitize the insulin secretory response to glucose in rats (Mason et al., 1999). Relationships between NEFA and insulin resistance in dairy cattle warrant further investigation.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication June 22, 2005. Accepted for publication March 6, 2006.
| REFERENCES |
|---|
|
|
|---|
on glucose metabolism and growth hormone secretion in steers. Am. J. Vet. Res. 62:794798.[Medline]This article has been cited by other articles:
![]() |
P. Bossaert, J. L. M. R. Leroy, S. De Vliegher, and G. Opsomer Interrelations Between Glucose-Induced Insulin Response, Metabolic Indicators, and Time of First Ovulation in High-Yielding Dairy Cows J Dairy Sci, September 1, 2008; 91(9): 3363 - 3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. A. Pires, J. B. Pescara, and R. R. Grummer Reduction of Plasma NEFA Concentration by Nicotinic Acid Enhances the Response to Insulin in Feed-Restricted Holstein Cows J Dairy Sci, October 1, 2007; 90(10): 4635 - 4642. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |